Search clinical trials for: sporadic ataxia

Total 491 results

S. Andrea Hospital

Unknown

Riluzole in Patients With Spinocerebellar Ataxia Type 7

SCA7

Italy
Kissei Pharmaceutical Co., Ltd.

Completed

An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Adverum Biotechnologies, Inc.
Adverum Biotechnologies SAS, a wholly owned subsidiary of Adverum Biotechnologies...

Completed

A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)

Friedreich's Ataxia

France
Randi J. Hagerman, MD

Completed

Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone

Fragile X-associated Tremor/Ataxia Syndrome

United States
National Cancer Institute (NCI)

Terminated

A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

Medullary Thyroid Carcinoma

United States
Schülke & Mayr GmbH

Completed

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

Austria, Germany
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated) (ATM)

Choroidal Neovascularization

France
University Hospital Tuebingen
National Center for Tumor Diseases, Heidelberg

Completed

WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data (NF2)

Neurofibromatosis Type 2 | Vestibular Schwannoma | Acoustic Neuroma

Germany
University College, London

Unknown

Imaging Neuromelanin and Iron in Dystonia/Parkinsonism

Mitochondrial Diseases | Dystonia, Familial | Sporadic Dystonia | Parkinson Disease, Juvenile | Neurodegeneration With Brain Iron Accumulation 5
Dr. John A. Thiel Medical Professional Corporation

Unknown

Baclofen/Diazepam Supps for Treatment of Pelvic Floor Myalgia (BDS)

Pelvic Floor Dyssynergia
Horizon Pharma Ireland, Ltd., Dublin Ireland
Friedreich's Ataxia Research Alliance

Completed

Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study (STEADFAST)

Friedreich's Ataxia

United States
Horizon Pharma Ireland, Ltd., Dublin Ireland
Friedreich's Ataxia Research Alliance

Completed

Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia (STEADFAST)

Friedreich's Ataxia

United States
Novartis Pharmaceuticals

Completed

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
Kathleen Sienko

Completed

Augmenting Balance in Individuals With Cerebellar Ataxias

Cerebellar Ataxia

United States
Santhera Pharmaceuticals

Completed

Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)

Freidreich's Ataxia

Germany, Netherlands, France, Austria, Belgium
Neuren Pharmaceuticals Limited
Baylor College of Medicine; International Rett Syndrome Foundation

Completed

A Safety Study of NNZ-2566 in Patients With Rett Syndrome

Rett Syndrome

United States
Brainsway

Completed

The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease

Machado Joseph Disease (SCA3)

Israel
Chengdu PLA General Hospital

Completed

The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis
Rigshospitalet, Denmark

Unknown

RGD PET/MRI in Sporadic Vestibular Schwannoma

Acoustic Neuroma

Denmark
Currax Pharmaceuticals
Henry Ford Hospital

Completed

Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers

Healthy

United States
Johns Hopkins University

Completed

Baclofen Treatment of Ataxia Telangiectasia

Ataxia Telangiectasia

United States
GlaxoSmithKline

Completed

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Carcinoma, Renal Cell

United States
Horizon Pharma Ireland, Ltd., Dublin Ireland
Friedreich's Ataxia Research Alliance

Completed

Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia (STEADFAST)

Friedreich's Ataxia

United States
Hacettepe University

Completed

The Effects Of Whole Body Vibration On Postural Control In Patients With Ataxia

Ataxia

Turkey
NHS Tayside
University of Dundee

Completed

Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone (RAMP)

Ataxia-Telangiectasia

United Kingdom
Johann Wolfgang Goethe University Hospital
CSL Behring

Completed

Susceptibility to Infections in Ataxia Telangiectasia

Infections | Lung Disease | Immunodeficiency | Ataxia Telangiectasia
Johann Wolfgang Goethe University Hospital

Unknown

Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia

Ataxia Telangiectasia

Germany
University of Sao Paulo General Hospital

Unknown

Effects of Deep Brain Stimulation of the Dentate Nucleus on Cerebellar Ataxia

Cerebellar Ataxia

Brazil
Augusta University
National Institutes of Health (NIH)

Completed

Randomized Controlled Trial of Home Versus Office Biofeedback for Constipation

Constipation | Dyssynergia
Assistance Publique - Hôpitaux de Paris

Completed

Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 (AOA1)

Ataxia-oculomotor Apraxia 1

France
EndoCeutics Inc.

Completed

DHEA Against Vaginal Atrophy - Safety Study of 12 Months

Vaginal Atrophy

United States, Canada
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients (RESILIENT)

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
Hospices Civils de Lyon

Completed

Clinical Interest of the Temporary Urethral Stent Allium " Bulbar Urethral Stent " in the Treatment of Detrusor Sphincter Dyssynergia (ALLIUM)

Detrusor Striated Sphincter Dyssynergia (DSSD)

France
University of Sao Paulo General Hospital

Unknown

Cerebellar Non-invasive Stimulation in Ataxias

Cerebellar Ataxia

Brazil
Imperial College London

Unknown

Effect of Nicotinamide in Friedreich's Ataxia

Neurodegenerative Disorders

United Kingdom
National Human Genome Research Institute (NHGRI)

Completed

Gene Analysis of Parkinson's Disease

Parkinson's Disease

United States
National Institute of Neurological Disorders and...

Completed

Immune Abnormalities in Sporadic Inclusion Body Myositis

Myositis | Sporadic | Inclusion Body

United States
M.D. Anderson Cancer Center
Ariad Pharmaceuticals

Withdrawn

Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)

Leukemia | FLT3-Mutated Acute Myeloid Leukemia | FLT3-Mutated High-Risk Myelodysplastic Syndrome
Beth Israel Deaconess Medical Center
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia (TMS)

Spinocerebellar Ataxia

United States
University of California, Davis
National Institute on Aging (NIA); Forest Laboratories

Completed

Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome

Fragile X-Associated Tremor/Ataxia Syndrome | Fragile X Premutation Carriers

United States
National Pediatric Neuroinflammation Organization...

Completed

Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome (OMS)

Opsoclonus-myoclonus Syndrome

United States
Azienda Policlinico Umberto I

Completed

A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients

Friedreich Ataxia

Italy
Oregon Health and Science University

Completed

Mindfulness Meditation for Subjects With Severe Speech and Physical Impairments (MSPi)

Cerebral Palsy | Physical Impairments | Cerebral Ataxia | locked-in Syndrome

United States
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN); Repligen Corporation

Completed

Safety of RG2077 in Patients With Multiple Sclerosis

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

United States
Meir Medical Center

Unknown

Machado-Joseph Disease in Israel

Spinocerebellar Ataxia 3

Israel
Novartis Pharmaceuticals

Completed

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) (EXIST-2)

Lymphangioleiomyomatosis (LAM) | Tuberous Sclerosis Complex (TSC)

United States, United Kingdom, Germany, Italy, Russian Federation, Netherlands, Japan, Canada, Poland, France, Spain
Shandong University

Unknown

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

Acute Myeloid Leukemia

China
University of Florida
National Institute on Aging (NIA)

Completed

Emotional Communication Disorders in Cerebellar Disease

Cerebellar Diseases

United States
Richard Barohn, MD

Completed

Arimoclomol in Sporadic Inclusion Body Myositis

Inclusion Body Myositis

United States, United Kingdom

Search clinical trials for: sporadic ataxia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations